About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical firm focused on discovering, developing, and commercializing human medicines. Its key therapeutic areas include diabetes (insulins like Humalog and Humulin, plus treatments such as Trulicity, Jardiance, and Trajenta), oncology, immunology, and neuroscience. The company also produces animal health products through its Elanco division.
Why it matters
Eli Lilly is one of the largest pharmaceutical companies by market capitalization, with a strong presence in the diabetes market, a sector driven by rising global prevalence. Its pipeline includes blockbuster drugs like Trulicity and Taltz, and it competes with Novo Nordisk, Sanofi, and Merck. Investors monitor LLY for its R&D output, patent expirations, and regulatory decisions that can impact revenue streams.
Company site ↗